Health care resources, no matter how represented, are ultimately finite. Trade-offs occur as spending in one area means that those same resources are unavailable to fund another program. In spite of this, U.S. policymakers remain reluctant to engage in
Read More...
Read the complete post at http://healthaffairs.org/blog/2015/09/01/the-value-and-limits-of-economic-evaluation-in-policy-analysis/
Posted
Sep 01 2015, 06:35 AM
by
Health Affairs Blog
Filed under: Global Health, Quality, Comparative Effectiveness, Research, Population Health, Featured, Payment Policy, Costs and Spending, Medicaid and CHIP, Equity and Disparities, Drugs and Medical Technology, Health Policy, WHO, hepatitis C, health economics, PCORI, heart disease, cost-effectiveness, malaria, QUALY